Lexpos News

Pharmacy owners across Yorkshire & the Humber and the West Midlands are invited to meet the Community Pharmacy England team to discuss the issues that matter to you. Chief Executive Janet Morrison and the team are heading to Leeds on Tuesday 16th July and then onto Birmingham on Wednesday 17th July to talk directly to [...]

The post Yorkshire & the Humber and West Midlands Pharmacy Owners: Book your place for our regional roadshows appeared first on Community Pharmacy England.

EMIS Pinnacle started rolling out the GP Connect Update Record feature to all community pharmacy teams using PharmOutcomes from Friday 28th June 2024. Initially, this covers Hypertension Case-finding Service and Pharmacy Contraception Service consultations. Update Record is a new feature that CPCF IT system suppliers have been adding to their systems, with Cegedim and Positive [...]

The post GP Connect: Update Record rolls out to most pharmacies appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (28/06/2024) confirmed the following list of price concessions for June 2024. This announcement comes late in the month and follows the decision to impose changes to concessions pricing from April 2024 to try to manage purchase margins. DHSC has applied its new margin reduction formula as a final [...]

The post DHSC’s June 2024 Price Concessions – 2nd Update appeared first on Community Pharmacy England.

Following a request by Community Pharmacy England, NHS England and the Department of Health and Social Care have agreed to extend the claim period for the Discharge Medicines Service (DMS) to three months; currently claims have to be made by the 5th of the month following that in which the final stage that the pharmacy [...]

The post DMS: Claim period extended to three months appeared first on Community Pharmacy England.

As previously announced, regulations have come into force to restrict the prescribing and supply of puberty suppressing hormones / gonadotrophin releasing hormone (GnRH) analogues to children and young people under 18 for the purposes of gender dysphoria / gender incongruence. During the period of the emergency ban (currently from 3 June to 3 September 2024), [...]

The post Regulations restricting the sale and supply of gonadotrophin-releasing hormone analogues appeared first on Community Pharmacy England.